GlassScriptPhysician profile
Aaron Michael Lewis
NPI 1689933491
$10,761.38
in general payments reported to CMS, 2019-2025
22 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,975 · 2020: $220 · 2021: $3,573 · 2022: $3,354 · 2023: $114 · 2024: $1,395 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $880 · Travel and Lodging: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $880.01 |
| Travel and Lodging | $760.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,181.45 | 2019-2024 | |
| Enterra Medical, INC. | $1,182.41 | 2022-2024 | |
| Medtronic, INC. | $450.66 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $199.24 | 2022-2024 | Gattex |
| Abbvie INC. | $198.54 | 2023-2025 | |
| Allergan, INC. | $110.21 | 2021 | |
| Conmed Corporation | $62.50 | 2025 | Airseal, Conmed Specimen Retrieval |
| Hologic Sales and Service, LLC | $46.50 | 2024 | Trunode, Localizer |
| Portola Pharmaceuticals, LLC | $43.40 | 2019-2020 | |
| Tela Bio, INC. | $39.50 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Zimmer Biomet Holdings, INC. | $35.00 | 2025 | Ribfix Titan |
| Medtronic USA, INC. | $30.36 | 2019 | |
| Ambu INC. | $20.42 | 2022 | |
| Z-Medica, LLC | $20.26 | 2020 | |
| Polynovo North America LLC | $20.24 | 2025 | Novosorb Btm |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.42 | 2023 | Lynparza, Keytruda |
| Astrazeneca Pharmaceuticals LP | $19.38 | 2023 | Andexxa |
| Alexion Pharmaceuticals, INC. | $18.93 | 2022 | |
| Endogastric Solutions, INC | $18.80 | 2022 | |
| Merit Medical Systems INC | $16.34 | 2022 | |
| Endologix LLC | $15.86 | 2020 | |
| Myriad Genetic Laboratories, INC. | $11.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.